N-myristoyltransferase: A potential novel diagnostic marker for colon cancer
2007

N-myristoyltransferase: A potential novel diagnostic marker for colon cancer

Sample size: 13 publication Evidence: moderate

Author Information

Author(s): Anuraag Shrivastav, Shailly Varma, Anurag Saxena, John DeCoteau, Rajendra K Sharma

Primary Institution: University of Saskatchewan

Hypothesis

Can N-myristoyltransferase (NMT) serve as a diagnostic marker for colon cancer?

Conclusion

NMT expression and localization differences in blood and bone marrow may help in diagnosing colon cancer.

Supporting Evidence

  • NMT activity was higher in the peripheral blood mononuclear cells of tumor-bearing rats compared to controls.
  • Strong NMT expression was observed in PBMC of colon cancer patients.
  • NMT localization was primarily nuclear in bone marrow cells of tumor-bearing hosts.

Takeaway

This study found that a protein called NMT is more active in people with colon cancer, which could help doctors find cancer without needing surgery.

Methodology

Blood samples were collected from colon cancer patients and control subjects, and NMT activity and expression were analyzed using immunohistochemistry.

Limitations

The study suggests a need for larger sample sizes to validate findings.

Participant Demographics

8 colon cancer patients and 5 control subjects, with a mix of ages and sexes.

Digital Object Identifier (DOI)

10.1186/1479-5876-5-58

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication